Amendment to Paid-in Capital Increase Decision
페니트리움바이오
187660
Signal Score
Historical Avg Return (5d)
+0.31%
Data Coverage
100%n=2386
Risk-adjusted indicator based on 2386 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Event: Paid-in Capital Increase (Amendment)
AI Analysis Summary
Penetrium Bioscience Inc. has filed an amendment to its Material Fact Report regarding a decision on a paid-in capital increase. While specific financial figures are not available, a capital increase typically leads to share dilution, potentially negatively impacting existing shareholder value. The amendment suggests changes to previously disclosed terms, which could affect the final dilution rate and funding size.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.